BREAKING

Protagonist Therapeutics Jumps 7.0% in Broad Rally 24 minutes ago Valaris Limited Drops 6.7% in Broad Selloff 1 hour ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 2 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 24 minutes ago Valaris Limited Drops 6.7% in Broad Selloff 1 hour ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 2 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago

ADVERTISEMENT

NB

NBIX

All NBIX Content

22 articles, transcripts, and reports

Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release

April 14, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Sec Form 8K

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 8K

April 7, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 M&A Release

April 6, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release

March 26, 20261 min read

ADVERTISEMENT

Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Management Update

March 17, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Forum

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Forum

March 10, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Q4 2025 Earnings Call Transcript

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Call dated Feb. 11, 2026 Corporate Participants: Todd Tushla — Vice President...

March 10, 202648 min read

Neurocrine Biosciences, Inc (NBIX) Leerink Global Healthcare Conference.

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference

February 24, 20261 min read

ADVERTISEMENT

Neurocrine Biosciences, Inc (NBIX) TD Cowen 46th Annual Health Care Conference

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference

February 24, 20261 min read

Neurocrine Biosciences, Inc (NBIX) Sec Form 10K

Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 10K

February 12, 20261 min read